Pages that link to "Q50358163"
Jump to navigation
Jump to search
The following pages link to Novel SOST gene mutation in a sclerosteosis patient and her parents (Q50358163):
Displaying 9 items.
- The osteocyte as a therapeutic target in the treatment of osteoporosis (Q27009129) (← links)
- A review of osteocyte function and the emerging importance of sclerostin (Q34264395) (← links)
- A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis (Q35578826) (← links)
- A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice (Q35755034) (← links)
- DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter (Q35816932) (← links)
- Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches (Q38128460) (← links)
- Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family (Q40631856) (← links)
- MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis (Q47428797) (← links)
- Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis (Q51673654) (← links)